Up next

Autoplay

Dr. Kudchadkar on the FDA Approval of Avelumab in Merkel Cell Carcinoma

1 Views • 07/17/23
Share
Embed
administrator
administrator
Subscribers
0

Ragini Kudchadkar, MD, assistant professor, Department of Hematology and Medical Oncology, associate director, Hematology and Medical Oncology Fellowship Program-Clinical/Service, Emory University School of Medicine, discusses the FDA approval of avelumab for the treatment of patients with Merkel cell carcinoma.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay